Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2002 Jul;161(1):195–206. doi: 10.1016/S0002-9440(10)64171-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2002, American Society for Investigative Pathology

PMC Copyright notice

Figure 6. — IP-10/CXCL10 serum levels are related with disease duration in patients affected by GD. A: Mean ± SD. IP-10/CXCL10 serum levels in GD are significantly higher (P < 0.05) in comparison with age- and sex-matched healthy patients, although in a large number of GD IP-10/CXCL10 levels overlaps with controls with high SD. B: Analysis of IP-10/CXCL10 serum levels in patients with different duration of GD. IP-10/CXCL10 serum levels are inversely correlated with the duration of the disease, the highest levels being a property of patients with recent-onset GD (R² = 0.146, P < 0.05). C: Analysis of MDC/IP-10 ratio serum levels in patients with different duration of GD. The ratio between MDC/CCL22 and IP-10/CXCL10 serum levels is strictly correlated with the duration of the disease, the highest levels being a property of patients with late-onset GD (R² = 0.2198, P < 0.005).